Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Although the core cerebrospinal fluid Alzheimer's disease (AD) biomarkers amyloid-β (Aβ
) and tau show a high diagnostic accuracy, there are still limitations due to overlap in the biomarker levels with other neurodegenerative and dementia disorders. During Aβ
production and clearance in the brain, several other Aβ peptides and amyloid precur...
Alternative Titles
Full title
Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1868336474
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1868336474
Other Identifiers
ISSN
1752-0363
E-ISSN
1752-0371
DOI
10.2217/bmm-2016-0276
